Arbor Biotechnologies logo

Arbor Biotechnologies Funding & Investors

Cambridge, MA

Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

arbor.bio

Total Amount Raised: $230,600,000

Arbor Biotechnologies Funding Rounds

  • Series B

    $215,000,000

    Series B Investors

    ABG
    TCG Crossover Management
    Temasek Holdings
    Section 32
    Woodline Partners
    Ridgeback Capital Management
    GreatPoint Ventures
    T. Rowe Price
    Henderson Global Investors
    Illumina Ventures
    Ono Venture Investment
    Vertex Pharmaceuticals
    Deep Track Capital
    Surveyor Capital
    Tekla Capital Management
    Arch Venture Partners
    Tao Capital Partners
    Logos Global Management
    ArrowMark Partners
  • Series A

    $15,600,000

    Series A Investors

    Arch Venture Partners
    Alexandria Real Estate Equities
Funding info provided by Diffbot.